Sodium thiosulfate eye drops BYON5667
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sodium thiosulfate eye drops BYON5667, covering 2024-01-05 to 2024-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985 [Phase 1, Phase 2]